New combo pill could help millions with uncontrolled diabetes
NCT ID NCT06571591
First seen Nov 19, 2025 · Last updated May 25, 2026 · Updated 18 times
Summary
This study tested whether adding pioglitazone to two common diabetes drugs (metformin and empagliflozin) helps lower blood sugar more effectively. About 600 adults with type 2 diabetes whose blood sugar was not well controlled took either pioglitazone or a placebo for several weeks. The main goal was to see if the extra drug improved HbA1c levels without causing serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Celltrion
Incheon, South Korea
Conditions
Explore the condition pages connected to this study.